Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05930561 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

4D-150 in Patients With Diabetic Macular Edema

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 1 of 6 sitesv7
  2. Primary completion date: Feb 29, 2028 to Feb 28, 2029 Primary endpoints: 1 to 2 · Trial status: Recruiting to Active, Not Recruiting · Study sites: 15 to 6 · 3 morev6 Show 6 more changesShow less
    • Primary endpoints: 1 to 2
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 15 to 6
    • Completion date: Jul 1, 2028 to Feb 28, 2029
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: 4 to 3

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv5
  4. Study sites revised (15)v4 See this version in full on ClinicalTrials.gov ↗
  5. Study sites: 7 to 15 Eligibility criteria expanded, about 13 words · Study arms: 6 to 5v3 Show 2 more changesShow less
    • Eligibility criteria expanded, about 13 words
    • Study arms: 6 to 5

    See this version in full on ClinicalTrials.gov ↗

  6. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 7 · Start date changed from estimate of Sep 30, 2023 to Aug 9, 2023v2 Show 2 more changesShow less
    • Study sites: 0 to 7
    • Start date changed from estimate of Sep 30, 2023 to Aug 9, 2023
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).
Trial Details
NCT Number NCT05930561
Lead Sponsor 4D Molecular Therapeutics
Conditions Diabetic Macular Edema, Diabetic Retinopathy
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov